Paul Boni

Paul Boni is the Consulting CFO and Founder of Aviridi. Prior to Grail, he worked at the $1bn generalist hedge fund, PAW partners, where he was responsible for investments in the healthcare sector, covering biotechnology, health insurance, pharmaceuticals and medical devices.

Paul started his career as an investment analyst on Wall Street covering the global biotechnology and pharmaceutical sectors at Mehta and Islay (now Mehta Partners and Orbimed Advisors). In this role, he developed several sector tracking systems, including a biotech stock index, a developmental product database and a scoring algorithm.

He later worked as a sell side analyst covering the biotechnology sector and also served as Chief Financial Officer at Mojave Therapeutics, a start-up biotechnology company.

Paul has a degree in biology from Harvard University.

Paul Boni is the Consultant at Aviridi, based in New York, New York, United States, North America. With a background in Biotechnology, Paul Boni has a rich history of leadership and innovation.Paul Boni studied Certificate biology at Harvard University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.